Home/Filings/SCHEDULE 13D/A/0001072613-25-000858
SCHEDULE 13D/A//SEC Filing

Marker Therapeutics, Inc. SCHEDULE 13D/A

Accession 0001072613-25-000858

CIK 0001694560other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 4:22 PM ET

Size

79.9 KB

Accession

0001072613-25-000858

Issuer

New Enterprise Associates 16, L.P.

CIK 0001694560

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001694560

Filing Metadata

Form type
SCHEDULE 13D/A
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:22 PM ET
Size
79.9 KB